triazoles has been researched along with Atypical Mycobacterial Infection, Disseminated in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atmakur, K; Bingi, C; Emmadi, NR; Kotapalli, SS; Nanubolu, JB; Ummanni, R | 1 |
| Al-Shair, K; Denning, DW; Harris, C; Lowes, D; Morris, J; Newton, PJ; Rautemaa-Richardson, R | 1 |
| Iseman, MD; Peloquin, CA; Schwiesow, JN | 1 |
3 other study(ies) available for triazoles and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
Synthesis and evaluation of novel fluorinated pyrazolo-1,2,3-triazole hybrids as antimycobacterial agents.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Click Chemistry; Halogenation; Humans; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Pyrazoles; Structure-Activity Relationship; Triazoles | 2015 |
Predictors of mortality in chronic pulmonary aspergillosis.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; C-Reactive Protein; Chronic Disease; Female; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Prognosis; Pulmonary Aspergillosis; Pulmonary Disease, Chronic Obstructive; Quality of Life; Retrospective Studies; Risk Factors; Serum Albumin, Human; Survival Analysis; Triazoles; United Kingdom; Young Adult | 2017 |
Concomitant use of voriconazole and rifabutin in a patient with multiple infections.
Topics: Adult; Antibiotics, Antitubercular; Antifungal Agents; Aspergillus fumigatus; Drug Interactions; Female; Humans; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Pulmonary Aspergillosis; Pyrimidines; Rifabutin; Triazoles; Voriconazole | 2008 |